Repligen Corporation
- RGEN
- NASDAQ
- Medical - Instruments & Supplies
- Bioprocessing Equipment
- Biopharma Supplies
$175.42
Today −4.75%Quote Oct 16, 2026, 08:00 PM UTC
−1.55%over the last month
Max drawdown −15.8%From 1-month high −9.8%3 months +20.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.90B
Quote Oct 16
Next earnings
Oct 27
Expected, not confirmed
Analyst target
$176.17
+0.4% from here
Floor
$175.23
0.1% below price
Where the price sits
24 analysts
Analyst range, low to high
$142.00$225.00
- Price $175.42
- Resistance $176.09–$177.86
- Consensus $176.17
The price is just above its floor and right under resistance. Analysts' average target sits about 0% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RGENPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Instruments & Supplies
Employees
2,000
Founded
1981